Use of Over-the-Counter Analgesics Is Not Associated With Acute Decompensation in Patients With Cirrhosis

Clinical Gastroenterology and Hepatology

Volumn 7, Issue 9, 2009, Pages 994-999

  Khalid, Sakib K ^a,b   Lane, Jill ^a   Navarro, Victor ^a,c   Garcia Tsao, Guadalupe ^a,b  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b VA CONNECTICUT HEALTHCARE SYSTEM   (United States)

^c THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANALGESIC AGENT; NON PRESCRIPTION DRUG; NONSTEROID ANTIINFLAMMATORY AGENT; PARACETAMOL;

ADULT; AGED; ALCOHOL CONSUMPTION; ALCOHOL LIVER CIRRHOSIS; ARTICLE; CASE CONTROL STUDY; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG USE; FEMALE; HUMAN; LIVER CIRRHOSIS; LIVER DISEASE; MALE; PROSPECTIVE STUDY; STRUCTURED QUESTIONNAIRE;

ACETAMINOPHEN; ADULT; AGED; AGED, 80 AND OVER; ALCOHOL DRINKING; ANALGESICS, NON-NARCOTIC; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CASE-CONTROL STUDIES; FEMALE; HOSPITALIZATION; HUMANS; LIVER; LIVER CIRRHOSIS; MALE; MIDDLE AGED; NONPRESCRIPTION DRUGS; PAIN; PROSPECTIVE STUDIES; QUESTIONNAIRES; YOUNG ADULT;

EID: 69249230760     PISSN: 15423565     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cgh.2009.04.015     Document Type: Article

References (24)

1. Zimmerman H.J., and Maddrey W.C. Acetaminophen (paracetamol) hepatotoxicity with regular intake of alcohol: analysis of instances of therapeutic misadventure. Hepatology 22 (1995) 767-773
2. Ostapowicz G., Fontana R.J., Schiodt F.V., et al. Results of a prospective study of acute liver failure at 17 tertiary care centers in the United States. Ann Intern Med 137 (2002) 947-954
3. Larson A.M., Polson J., Fontana R.J., et al. Acetaminophen-induced acute liver failure: results of a United States multicenter, prospective study. Hepatology 42 (2005) 1364-1372
4. Skinner H.A., and Sheu W.J. Reliability of alcohol use indices. The Lifetime Drinking History and the MAST. J Stud Alcohol 43 (1982) 1157-1170
5. Kamath P.S., Wiesner R.H., Malinchoc M., et al. A model to predict survival in patients with end-stage liver disease. Hepatology 33 (2001) 464-470
6. D'Amico G., Garcia-Tsao G., and Pagliaro L. Natural history and prognostic indicators of survival in cirrhosis. A systematic review of 118 studies. J Hepatol 44 (2006) 217-231
7. Black M. Acetaminophen hepatotoxicity. Annu Rev Med 35 (1984) 577-593
8. Seeff L.B., Cuccherini B.A., Zimmerman H.J., et al. Acetaminophen hepatotoxicity in alcoholics. A therapeutic misadventure. Ann Intern Med 104 (1986) 399-404
9. Westphal J.F., and Brogard J.M. Drug administration in chronic liver disease. Drug Saf 17 (1997) 47-73
10. Carson J.L., Strom B.L., Duff A., et al. Safety of nonsteroidal anti-inflammatory drugs with respect to acute liver disease. Arch Intern Med 153 (1993) 1331-1336
11. Fry S.W., and Seeff L.B. Hepatotoxicity of analgesics and anti-inflammatory agents. Gastroenterol Clin North Am 24 (1995) 875-905
12. Mirouze D., Zipser R.D., and Reynolds T.B. Effects of inhibitors of prostaglandin synthesis on induced diuresis in cirrhosis. Hepatology 3 (1983) 50-55
13. Planas R., Arroyo V., Rimola A., et al. Acetylsalicylic acid suppresses the renal hemodynamic effect and reduces the diuretic action of furosemide in cirrhosis with ascites. Gastroenterology 84 (1983) 247-252
14. Boyer T.D., Zia P., and Reynolds T.B. Effect of indomethacin and prostaglandin A1 on renal function and plasma renin activity in alcoholic liver disease. Gastroenterology 77 (1979) 215-222
15. Perez-Ayuso R.M., Arroyo V., Camps J., et al. Evidence that renal prostaglandins are involved in renal water metabolism in cirrhosis. Kidney Int 26 (1984) 72-80
16. Quintero E., Gines P., Arroyo V., et al. Sulindac reduces the urinary excretion of prostaglandins and impairs renal function in cirrhosis with ascites. Nephron 42 (1986) 298-303
17. Laffi G., Daskalopoulos G., Kronborg I., et al. Effects of sulindac and ibuprofen in patients with cirrhosis and ascites. An explanation for the renal-sparing effect of sulindac. Gastroenterology 90 (1986) 182-187
18. Brater D.C., Anderson S.A., and Brown-Cartwright D. Reversible acute decrease in renal function by NSAIDs in cirrhosis. Am J Med Sci 294 (1987) 168-174
19. Antillon M., Cominelli F., Lo S., et al. Effects of oral prostaglandins on indomethacin-induced renal failure in patients with cirrhosis and ascites. J Rheumatol Suppl 20 (1990) 46-49
20. Ackerman Z., Cominelli F., and Reynolds T.B. Effect of misoprostol on ibuprofen-induced renal dysfunction in patients with decompensated cirrhosis: results of a double-blind placebo-controlled parallel group study. Am J Gastroenterol 97 (2002) 2033-2039
21. Claria J., Kent J.D., Lopez-Parra M., et al. Effects of celecoxib and naproxen on renal function in nonazotemic patients with cirrhosis and ascites. Hepatology 41 (2005) 579-587
22. Guevara M., Abecasis R., and Terg R. Effect of celecoxib on renal function in cirrhotic patients with ascites. A pilot study. Scand J Gastroenterol 39 (2004) 385-386
23. Wong F., Massie D., Hsu P., et al. Indomethacin-induced renal dysfunction in patients with well-compensated cirrhosis. Gastroenterology 104 (1993) 869-876
24. De Lédinghen V., Heresbach D., Fourdan O., et al. Anti-inflammatory drugs and variceal bleeding: a case-control study. Gut 44 (1999) 270-273